FORTREA HOLDINGS INC. Stock-Based Compensation
FORTREA HOLDINGS INC. (FTRE) reported Stock-Based Compensation of $24.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-29
- FORTREA HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $12.60M, a 44.49% decline year-over-year.
- FORTREA HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $11.40M, a 21.92% decline year-over-year.
- FORTREA HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $14.80M, a 3.27% decline year-over-year.
- FORTREA HOLDINGS INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $22.30M, a 71.54% increase year-over-year.
- FORTREA HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2025 was $74.40M, a 27.40% increase from fiscal 2024.
- FORTREA HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2024 was $58.40M, a 36.77% increase from fiscal 2023.
- FORTREA HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2023 was $42.70M, a 68.11% increase from fiscal 2022.
- FORTREA HOLDINGS INC. share-based payment arrangement, noncash expense for fiscal 2022 was $25.40M, a 7.64% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $12.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $24.00M 10-Q · filed 2026-07-29 | $38.80M derived: sum of 3 quarters · filed 2026-07-29 | $61.10M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | $11.40M 10-Q · filed 2026-05-05 | $26.20M derived: sum of 2 quarters · filed 2026-05-05 | $48.50M derived: sum of 3 quarters · filed 2026-05-05 | $71.20M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $14.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $37.10M derived: sum of 2 quarters · filed 2026-02-26 | $59.80M derived: sum of 3 quarters · filed 2026-07-29 | $74.40M 10-K · filed 2026-02-26 |
| 2025-09-30 | $22.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $45.00M derived: sum of 2 quarters · filed 2026-07-29 | $59.60M 10-Q · filed 2025-11-05 | $74.90M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $22.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $37.30M 10-Q · filed 2026-07-29 | $52.60M derived: sum of 3 quarters · filed 2026-07-29 | $65.60M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $14.60M 10-Q · filed 2026-05-05 | $29.90M derived: sum of 2 quarters · filed 2026-05-05 | $42.90M derived: sum of 3 quarters · filed 2026-05-05 | $57.90M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $15.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $28.30M derived: sum of 2 quarters · filed 2026-02-26 | $43.30M derived: sum of 3 quarters · filed 2026-02-26 | $58.40M 10-K · filed 2026-02-26 |
| 2024-09-30 | $13.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $28.00M derived: sum of 2 quarters · filed 2025-11-05 | $43.10M 10-Q · filed 2025-11-05 | $58.60M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $15.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $30.10M 10-Q · filed 2025-08-06 | $45.60M derived: sum of 3 quarters · filed 2026-02-26 | $56.70M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $15.10M 10-Q · filed 2025-05-12 | $30.60M derived: sum of 2 quarters · filed 2026-02-26 | $41.70M derived: sum of 3 quarters · filed 2026-02-26 | $51.10M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $15.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $26.60M derived: sum of 2 quarters · filed 2026-02-26 | $36.00M derived: sum of 3 quarters · filed 2026-02-26 | $42.70M 10-K · filed 2026-02-26 |
| 2023-09-30 | $11.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $20.50M derived: sum of 2 quarters · filed 2024-11-08 | $27.20M 10-Q · filed 2024-11-08 | $33.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $9.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $16.10M 10-Q · filed 2024-08-12 | $21.90M derived: sum of 3 quarters · filed 2025-03-03 | $28.30M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $6.70M 10-Q · filed 2024-05-24 | $12.50M derived: sum of 2 quarters · filed 2025-03-03 | $18.90M derived: sum of 3 quarters · filed 2025-03-03 | |
| 2022-12-31 | $5.80M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $12.20M derived: sum of 2 quarters · filed 2025-03-03 | $25.40M 10-K · filed 2025-03-03 | |
| 2022-09-30 | $6.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $19.60M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $13.20M 10-Q · filed 2023-08-14 | |||
| 2021-12-31 | $27.50M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |